PEOPLE - Beiersdorf makes appointment:
This article was originally published in Clinica
Thomas-Bernd Quaas has been designated as the new board of management chairman of German wound care and consumer products company Beiersdorf (Hamburg). He takes up the role on May 18, and will replace the experienced Rolf Kunisch, who will join the supervisory board. The long-standing Uwe Wolfer will also retire from the management board. Other new board appointees in May will be: Pieter Nota (brands) and Markus Pinger (supply chain).
You may also be interested in...
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.
FDA has little in the way of good information it can list on its CBD policy agenda so far, says Principal Deputy Commissioner Amy Abernethy. At recent regulatory conference, she said, "Like it or not, there is a massive human experiment going on right now. There’s CBD in most different product categories and people of many different backgrounds with potential vulnerabilities taking CBD."
FDA is worried about drug names that could appear to overstate efficacy and impact consumer and healthcare provider perceptions of the product.